ADVANCES IN BIOELECTRICAL ENGINEERING UNLOCK NEW POSSIBILITIES FOR IMPLANTED DEVICES
BIOENGINEERING BEYOND NEUROMODULATION
While most neuromodulation therapies provide an additional means of managing symptoms of chronic conditions, after bioengineering advances in bioelectronic medicine, a small implanted device now generates and delivers periodic digital doses to nerve bundles, creating a disease-fighting effect based on mechanisms similar to drug therapies.
SMALLER DEVICES WITH LONGER BATTERY LIFE
Implantable devices now have integrated electrodes built on the miniaturized pulse generators, eliminating the need for lead wires. Fast microchip processors, miniature lithium-ion batteries and wireless charging have spurred the development of small, easy-to-implant devices with more than a decade of projected battery life.
MICROSTIMULATION DOSAGE AT PRECISELY THE RIGHT LOCATION
With the discovery of the Inflammatory Reflex, SetPoint Medical researchers set out to characterize the pathway and harness it for clinical use. They worked to define the fibers in the vagus nerve to directly impact the spleen with the most precise, effective bioelectronic dose.
Direct stimulation of the vagus nerve using an electrode in contact with the nerve provides the most effective and predictable stimulation of the Inflammatory Reflex versus near field stimulators outside the body.
Measured biomarkers indicated SetPoint Medical’s approach has achieved meaningful anti-inflammatory response though brief, intermittent low-level stimulation. The impact of this stimulation lasted more than 24 hours, similar to taking a pill once a day.
SetPoint Medical Announces Data Supporting Continued Clinical Development of its Bioelectronic Device for T...Read Press Release from
October 23, 2018
SetPoint Medical Presents Positive Data from its Clinical Study of Bioelectronic Medicine for Treatment of...Read Press Release from
June 11, 2018
INVESTIGATIONAL DEVICE DISCLAIMER: The SetPoint Medical device is an investigational device. It is currently undergoing clinical evaluation under Food and Drug Administration’s Investigational Device Exemption and is not approved for commercial use.